Travere Therapeutics, Inc.
2020 Q4 - 2025 Q4 (21 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).
| All 13F Holders | Filing date | Value ($000s) | % of Holdings | Shares | Reporting period |
|---|---|---|---|---|---|
| 2025 Q4 | 2/12/2026 | 794 | 0.0% | 20,785 | 12/31/2025 |
| 2025 Q3 | 11/14/2025 | 497 | 0.0% | 20,785 | 9/30/2025 |
| 2025 Q2 | 8/13/2025 | 308 | 0.0% | 20,785 | 6/30/2025 |
| 2025 Q1 | 5/12/2025 | 372 | 0.0% | 20,785 | 3/31/2025 |
| 2024 Q4 | 2/10/2025 | 362 | 0.0% | 20,785 | 12/31/2024 |
| 2024 Q3 | 11/8/2024 | 291 | 0.0% | 20,785 | 9/30/2024 |
| 2024 Q2 | 8/8/2024 | 171 | 0.0% | 20,785 | 6/30/2024 |
| 2024 Q1 | 5/8/2024 | 433 | 0.0% | 19,235 | 3/31/2024 |
| 2023 Q4 | 2/9/2024 | 187 | 0.0% | 20,785 | 12/31/2023 |
| 2023 Q3 | 11/8/2023 | 186 | 0.0% | 20,785 | 9/30/2023 |
| 2023 Q2 | 8/11/2023 | 318 | 0.0% | 20,685 | 6/30/2023 |
| 2023 Q1 | 6/14/2023 | 433 | 0.0% | 19,235 | 3/31/2023 |
| 2022 Q4 | 6/14/2023 | 405 | 0.0% | 19,235 | 12/31/2022 |
| 2022 Q3 | 11/8/2022 | 605 | 0.0% | 24,555 | 9/30/2022 |
| 2022 Q2 | 8/5/2022 | 595 | 0.0% | 24,555 | 6/30/2022 |
| 2022 Q1 | 5/6/2022 | 633 | 0.0% | 24,555 | 3/31/2022 |
| 2021 Q4 | 2/8/2022 | 762 | 0.0% | 24,555 | 12/31/2021 |
| 2021 Q3 | 11/8/2021 | 607 | 0.0% | 25,038 | 9/30/2021 |
| 2021 Q2 | 8/10/2021 | 365 | 0.0% | 25,038 | 6/30/2021 |
| 2021 Q1 | 5/10/2021 | 568 | 0.0% | 22,765 | 3/31/2021 |
| 2020 Q4 | 2/8/2021 | 2,455 | 0.0% | 90,065 | 12/31/2020 |